Bone Biologics notified by Nasdaq over $1 minimum bid
Nasdaq notified Bone Biologics it failed to meet the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2) after 30 consecutive business days below $1.00. The company has until March 9, 2027 to regain compliance.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.